Cargando…
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes
Driven by oncogenic signaling, glutamine addiction exhibited by cancer cells often leads to severe glutamine depletion in solid tumors. Despite this nutritional environment that tumor cells often experience, the effect of glutamine deficiency on cellular responses to DNA damage and chemotherapeutic...
Autores principales: | Tran, Thai Q., Ishak Gabra, Mari B., Lowman, Xazmin H., Yang, Ying, Reid, Michael A., Pan, Min, O’Connor, Timothy R., Kong, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673162/ https://www.ncbi.nlm.nih.gov/pubmed/29107960 http://dx.doi.org/10.1371/journal.pbio.2002810 |
Ejemplares similares
-
IKKβ activates p53 to promote cancer cell adaptation to glutamine deprivation
por: Ishak Gabra, Mari B., et al.
Publicado: (2018) -
IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3
por: Reid, Michael A., et al.
Publicado: (2016) -
Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth
por: Ishak Gabra, Mari B., et al.
Publicado: (2020) -
Enzyme activated alkylating agents.
por: Ball, C. R., et al.
Publicado: (1973) -
Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction
por: Tran, Thai Q., et al.
Publicado: (2016)